P=NS), confirming anti-fibrotic rather than anti-inflammatory mechanism at this dose
Fagerberg B, Edwards S, Halmos T et al (2005) Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
The body has adapted to the medication, GI side effects have resolved, hormonal levels have reached a new baseline, and the brain reward system has partially recalibrated
It is especially effective at lightening skin tone, though, and while the effect can remain permanent, it does not always
Phentermine is also not recommended during pregnancy or for those taking certain psychiatric medications
Beyond the molecule's own profile, real-world risks cluster around administration and product quality